(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are Tesla, Geo Group, and Arcelor Mittal.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Tesla (TSLA) 976.70 4.07% 2021-12-22 07:30:05
2 Geo Group (GEO) 7.75 2.92% 2021-12-22 04:41:33
3 Arcelor Mittal (MT) 32.83 2.4% 2021-12-22 07:24:02
4 Smith & Nephew (SNN) 33.97 1.98% 2021-12-22 07:25:03
5 Huntington Bancshares (HBAN) 15.35 1.86% 2021-12-22 05:58:36
6 Novo Nordisk A/S (NVO) 108.05 1.73% 2021-12-22 07:24:10
7 Halliburton Company (HAL) 23.04 1.68% 2021-12-22 07:22:40
8 Viking Therapeutics (VKTX) 4.96 1.64% 2021-12-22 04:18:26
9 U.S. Bancorp (USB) 56.75 1.63% 2021-12-22 07:25:45
10 Caterpillar (CAT) 201.47 1.59% 2021-12-22 07:20:32

The three most active and biggest losers today are Castle Biosciences, Canopy Growth, and Alibaba.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Castle Biosciences (CSTL) 40.80 -4.72% 2021-12-22 04:16:13
2 Canopy Growth (CGC) 9.30 -3.73% 2021-12-22 07:26:18
3 Alibaba (BABA) 118.41 -3.72% 2021-12-22 04:38:42
4 Bilibili (BILI) 47.75 -3.16% 2021-12-22 04:36:52
5 Roper Industries (ROP) 460.00 -2.59% 2021-12-22 04:45:38
6 TherapeuticsMD (TXMD) 0.41 -2.36% 2021-12-22 07:33:46
7 Pinduoduo (PDD) 57.92 -2.34% 2021-12-22 07:32:53
8 DouYu (DOYU) 2.57 -2.28% 2021-12-22 07:31:46
9 Exact Sciences (EXAS) 80.55 -2.25% 2021-12-22 04:10:54
10 Genworth Financial (GNW) 3.92 -2.24% 2021-12-22 04:41:42

Most Active Premarket Winners today

1. Tesla (TSLA) – Premarket: 4.07%

NASDAQ Composite ended the session with Tesla rising 4.29% to $938.53 on Wednesday while NASDAQ Composite rose 2.4% to $15,341.09.

Volume

Today’s last reported volume for Tesla is 23103300, 11.8% below its average volume of 26196700.

Tesla’s last close was $938.53, 24.52% under its 52-week high of $1,243.49.

News about Tesla today

  • Musk offloads $528 million of Tesla shares as 10% stake unwinds. According to today’s article on Bloomberg Quint, "Elon Musk sold 583,611 shares in Tesla Inc. for $528 million, meaning he’s now more than three-quarters of the way to making good on his pledge to sell 10% of his stake in the electric carmaker.", "Musk has been offloading Tesla stock since asking his Twitter followers in November whether he should sell some of his stake. "
  • Elon Musk says he's sold enough Tesla stock to meet his 10% goal, after offloading another $548 million in shares. According to today’s article on Business Insider, "The billionaire, who in 2018 was awarded Tesla stock options that expire in August next year, faces a hefty tax bill from the withholding obligations that come when he exercises the options.", "The Democratic Senator said the tax code must be changed so Musk "stops freeloading off everyone else." But the billionaire Tesla boss shot down her comments, saying he would be paying "more taxes than any American in history this year."

Tesla’s Sales

Tesla’s sales growth is 49.9% for the current quarter and 37.7% for the next. The company’s growth estimates for the current quarter and the next is 81.6% and 102.5%, respectively.

Tesla’s Revenue

Year-on-year quarterly revenue growth grew by 56.8%, now sitting on 46.85B for the twelve trailing months.

Volatility

Tesla’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.11%, a negative 1.44%, and a positive 2.98%, respectively.

Tesla’s highest amplitude of average volatility was 4.56% (last week), 3.44% (last month), and 2.98% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Tesla’s stock is considered to be oversold (<=20).

Tesla’s Stock Yearly Top and Bottom Value

Tesla’s stock is valued at $938.53 at 07:34 EST, way below its 52-week high of $1,243.49 and way above its 52-week low of $539.49.

Tesla’s Moving Average

Tesla’s worth is below its 50-day moving average of $1,006.49 and way above its 200-day moving average of $758.25.

Previous days news about Tesla

  • Tesla (tsla) stock price and forecast: why is Tesla going to fall below $900 on Monday?. According to FXStreet on Monday, 20 December, "To end the week Tesla might be going all mainstream with the NYPD mulling over an order.", "However, the general negativity is likely to mean this is overlooked for now and we expect Tesla (TSLA) to drop below $900 today."
  • Did GM poke fun at Tesla with new hummer EV image? will Elon Musk respond?. According to Benzinga on Tuesday, 21 December, "Although General Motors, Tesla and Ford Motor Co (NYSE: F) all have their sites set on the market as well.", "The latest rivalrycould be between General Motors Co (NYSE: GM) and Tesla Inc (NASDAQ: TSLA) with the former taking a quick shot at Tesla’s upcoming Cybertruck."
  • Microsoft, Tesla fuel ESG gains for 32-year-old fidelity fund. According to Bloomberg Quint on Monday, 20 December, "But one Fidelity Investments mutual fund that’s been around for more than three decades is among this year’s best-performing sustainability-focused funds, with a 24% return, driven by shares of Microsoft Corp. and Tesla Inc., its top holdings.", "While its holdings also include renewables giants Vestas Wind Systems A/S and NextEra Energy Inc., Microsoft and Tesla account for more than a quarter of its total assets, according to the latest available data compiled by Bloomberg. "

More news about Tesla.

2. Geo Group (GEO) – Premarket: 2.92%

NYSE Composite ended the session with Geo Group jumping 2.87% to $7.53 on Wednesday while NYSE Composite rose 1.84% to $16,744.27.

Volume

Today’s last reported volume for Geo Group is 1316940, 44.13% below its average volume of 2357470.

Geo Group’s last close was $7.53, 31.55% below its 52-week high of $11.00.

The company’s growth estimates for the current quarter is a negative 5.6% and positive 45.5% for the next.

Geo Group’s Revenue

Year-on-year quarterly revenue growth declined by 4.7%, now sitting on 2.32B for the twelve trailing months.

Volatility

Geo Group’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.70%, a negative 1.38%, and a positive 2.14%, respectively.

Geo Group’s highest amplitude of average volatility was 2.16% (last week), 1.95% (last month), and 2.14% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Geo Group’s stock is considered to be overbought (>=80).

Geo Group’s Stock Yearly Top and Bottom Value

Geo Group’s stock is valued at $7.53 at 07:34 EST, way below its 52-week high of $11.00 and way higher than its 52-week low of $4.96.

Geo Group’s Moving Average

Geo Group’s worth is under its 50-day moving average of $8.11 and higher than its 200-day moving average of $7.21.

More news about Geo Group.

3. Arcelor Mittal (MT) – Premarket: 2.4%

NYSE Composite ended the session with Arcelor Mittal jumping 1.23% to $32.06 on Wednesday while NYSE Composite rose 1.84% to $16,744.27.

Volume

Today’s last reported volume for Arcelor Mittal is 3963060, 5.22% below its average volume of 4181510.

Arcelor Mittal’s last close was $32.06, 12.36% below its 52-week high of $36.58.

Arcelor Mittal’s Sales

Arcelor Mittal’s sales growth is 64.7% for the current quarter and 47.1% for the next. The company’s growth estimates for the present quarter and the next is 2536.8% and 1826.3%, respectively.

Arcelor Mittal’s Revenue

Year-on-year quarterly revenue growth grew by 76.2%, now sitting on 62.99B for the twelve trailing months.

Volatility

Arcelor Mittal’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.26%, a positive 0.82%, and a positive 2.13%, respectively.

Arcelor Mittal’s highest amplitude of average volatility was 1.08% (last week), 2.16% (last month), and 2.13% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcelor Mittal’s stock is considered to be overbought (>=80).

Arcelor Mittal’s Stock Yearly Top and Bottom Value

Arcelor Mittal’s stock is valued at $32.06 at 07:34 EST, way below its 52-week high of $36.58 and way higher than its 52-week low of $20.50.

Arcelor Mittal’s Moving Average

Arcelor Mittal’s value is higher than its 50-day moving average of $30.75 and higher than its 200-day moving average of $30.93.

More news about Arcelor Mittal.

4. Smith & Nephew (SNN) – Premarket: 1.98%

NYSE Composite ended the session with Smith & Nephew rising 3.77% to $33.31 on Wednesday, after two successive sessions in a row of gains. NYSE Composite jumped 1.84% to $16,744.27, following the last session’s upward trend on what was an all-around up trend exchanging session today.

Volume

Today’s last reported volume for Smith & Nephew is 471570, 21.06% below its average volume of 597452.

Smith & Nephew’s last close was $33.31, 27.74% under its 52-week high of $46.10.

Smith & Nephew’s Revenue

Year-on-year quarterly revenue growth declined by 4.8%, now sitting on 4.56B for the twelve trailing months.

Volatility

Smith & Nephew’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.67%, a negative 0.83%, and a positive 1.55%, respectively.

Smith & Nephew’s highest amplitude of average volatility was 1.27% (last week), 1.63% (last month), and 1.55% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Smith & Nephew’s stock is considered to be overbought (>=80).

Smith & Nephew’s Stock Yearly Top and Bottom Value

Smith & Nephew’s stock is valued at $33.31 at 07:34 EST, way below its 52-week high of $46.10 and higher than its 52-week low of $32.03.

Smith & Nephew’s Moving Average

Smith & Nephew’s worth is under its 50-day moving average of $34.59 and way below its 200-day moving average of $38.94.

More news about Smith & Nephew.

5. Huntington Bancshares (HBAN) – Premarket: 1.86%

NASDAQ Composite ended the session with Huntington Bancshares rising 3.65% to $15.07 on Wednesday, following the last session’s upward trend. NASDAQ Composite jumped 2.4% to $15,341.09, following the last session’s upward trend on what was an all-around positive trend exchanging session today.

Volume

Today’s last reported volume for Huntington Bancshares is 6621080, 38.07% below its average volume of 10692600.

Huntington Bancshares’s last close was $15.07, 10.88% below its 52-week high of $16.91.

The company’s growth estimates for the present quarter and the next is 22.2% and 25.9%, respectively.

Huntington Bancshares’s Revenue

Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 4.69B for the twelve trailing months.

Volatility

Huntington Bancshares’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.12%, a negative 0.57%, and a positive 1.34%, respectively.

Huntington Bancshares’s highest amplitude of average volatility was 2.16% (last week), 1.58% (last month), and 1.34% (last quarter), respectively.

Huntington Bancshares’s Stock Yearly Top and Bottom Value

Huntington Bancshares’s stock is valued at $15.07 at 07:34 EST, way under its 52-week high of $16.91 and way higher than its 52-week low of $12.00.

Huntington Bancshares’s Moving Average

Huntington Bancshares’s value is under its 50-day moving average of $15.93 and under its 200-day moving average of $15.34.

More news about Huntington Bancshares.

6. Novo Nordisk A/S (NVO) – Premarket: 1.73%

NYSE Composite ended the session with Novo Nordisk A/S jumping 2.59% to $106.21 on Wednesday, after two successive sessions in a row of gains. NYSE Composite jumped 1.84% to $16,744.27, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Volume

Today’s last reported volume for Novo Nordisk A/S is 2553940, 163.13% above its average volume of 970580.

Novo Nordisk A/S’s last close was $106.21, 8.4% below its 52-week high of $115.95.

Novo Nordisk A/S’s Sales

Novo Nordisk A/S’s sales growth is 7.9% for the present quarter and 11.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 6.9% and 12.5%, respectively.

Novo Nordisk A/S’s Revenue

Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 129.91B for the twelve trailing months.

Volatility

Novo Nordisk A/S’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.99%, a positive 0.21%, and a positive 1.52%, respectively.

Novo Nordisk A/S’s highest amplitude of average volatility was 5.21% (last week), 1.91% (last month), and 1.52% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Novo Nordisk A/S’s stock is considered to be overbought (>=80).

Novo Nordisk A/S’s Stock Yearly Top and Bottom Value

Novo Nordisk A/S’s stock is valued at $106.21 at 07:34 EST, below its 52-week high of $115.95 and way higher than its 52-week low of $66.59.

Novo Nordisk A/S’s Moving Average

Novo Nordisk A/S’s worth is under its 50-day moving average of $107.59 and way above its 200-day moving average of $90.32.

More news about Novo Nordisk A/S.

7. Halliburton Company (HAL) – Premarket: 1.68%

NYSE Composite ended the session with Halliburton Company rising 3.94% to $22.66 on Wednesday, after two sequential sessions in a row of gains. NYSE Composite rose 1.84% to $16,744.27, following the last session’s upward trend on what was an all-around positive trend trading session today.

Volume

Today’s last reported volume for Halliburton Company is 6914250, 29.91% below its average volume of 9866070.

Halliburton Company’s last close was $22.66, 15.29% below its 52-week high of $26.75.

The company’s growth estimates for the present quarter and the next is 154.5% and 77.8%, respectively.

Halliburton Company’s Revenue

Year-on-year quarterly revenue growth grew by 16%, now sitting on 13.37B for the twelve trailing months.

Volatility

Halliburton Company’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.60%, a negative 0.75%, and a positive 2.57%, respectively.

Halliburton Company’s highest amplitude of average volatility was 2.60% (last week), 3.01% (last month), and 2.57% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Halliburton Company’s stock is considered to be overbought (>=80).

Halliburton Company’s Stock Yearly Top and Bottom Value

Halliburton Company’s stock is valued at $22.66 at 07:34 EST, way below its 52-week high of $26.75 and way above its 52-week low of $17.23.

Halliburton Company’s Moving Average

Halliburton Company’s worth is under its 50-day moving average of $23.97 and higher than its 200-day moving average of $22.14.

More news about Halliburton Company.

8. Viking Therapeutics (VKTX) – Premarket: 1.64%

NASDAQ Composite ended the session with Viking Therapeutics sliding 1.41% to $4.88 on Wednesday, after two successive sessions in a row of losses. NASDAQ Composite rose 2.4% to $15,341.09, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.

Volume

Today’s last reported volume for Viking Therapeutics is 448280, 32.84% below its average volume of 667552.

Viking Therapeutics’s last close was $4.88, 51.64% below its 52-week high of $10.09.

The company’s growth estimates for the current quarter and the next is a negative 61.5% and a negative 46.7%, respectively.

Volatility

Viking Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.18%, a negative 0.67%, and a positive 2.35%, respectively.

Viking Therapeutics’s highest amplitude of average volatility was 3.09% (last week), 2.78% (last month), and 2.35% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Viking Therapeutics’s stock is considered to be oversold (<=20).

Viking Therapeutics’s Stock Yearly Top and Bottom Value

Viking Therapeutics’s stock is valued at $4.88 at 07:34 EST, way below its 52-week high of $10.09 and higher than its 52-week low of $4.81.

Viking Therapeutics’s Moving Average

Viking Therapeutics’s value is way under its 50-day moving average of $5.82 and way below its 200-day moving average of $6.03.

More news about Viking Therapeutics.

9. U.S. Bancorp (USB) – Premarket: 1.63%

NYSE Composite ended the session with U.S. Bancorp jumping 1.77% to $55.84 on Wednesday while NYSE Composite jumped 1.84% to $16,744.27.

Volume

Today’s last reported volume for U.S. Bancorp is 4405840, 16.83% below its average volume of 5297930.

U.S. Bancorp’s last close was $55.84, 11.38% under its 52-week high of $63.01.

U.S. Bancorp’s Sales

U.S. Bancorp’s sales growth is 1.4% for the present quarter and 1.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 15.2% and 20%, respectively.

U.S. Bancorp’s Revenue

Year-on-year quarterly revenue growth grew by 46.5%, now sitting on 22.64B for the twelve trailing months.

Volatility

U.S. Bancorp’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.85%, a negative 0.78%, and a positive 1.39%, respectively.

U.S. Bancorp’s highest amplitude of average volatility was 1.85% (last week), 1.61% (last month), and 1.39% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

U.S. Bancorp’s stock is considered to be overbought (>=80).

U.S. Bancorp’s Stock Yearly Top and Bottom Value

U.S. Bancorp’s stock is valued at $55.84 at 07:34 EST, way under its 52-week high of $63.01 and way above its 52-week low of $42.47.

U.S. Bancorp’s Moving Average

U.S. Bancorp’s value is below its 50-day moving average of $59.90 and under its 200-day moving average of $58.04.

More news about U.S. Bancorp.

10. Caterpillar (CAT) – Premarket: 1.59%

NYSE Composite ended the session with Caterpillar jumping 1.46% to $198.31 on Wednesday while NYSE Composite jumped 1.84% to $16,744.27.

Volume

Today’s last reported volume for Caterpillar is 1922200, 41.97% below its average volume of 3312880.

Caterpillar’s last close was $198.31, 19.61% below its 52-week high of $246.69.

Caterpillar’s Sales

Caterpillar’s sales growth is 18.1% for the present quarter and 19% for the next. The company’s growth estimates for the current quarter is 7.5% and a drop 0.7% for the next.

Caterpillar’s Revenue

Year-on-year quarterly revenue growth grew by 11.8%, now sitting on 43B for the twelve trailing months.

Volatility

Caterpillar’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.89%, a negative 0.30%, and a positive 1.27%, respectively.

Caterpillar’s highest amplitude of average volatility was 2.43% (last week), 1.12% (last month), and 1.27% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Caterpillar’s stock is considered to be overbought (>=80).

Caterpillar’s Stock Yearly Top and Bottom Value

Caterpillar’s stock is valued at $198.31 at 07:34 EST, way under its 52-week high of $246.69 and way higher than its 52-week low of $175.11.

Caterpillar’s Moving Average

Caterpillar’s value is below its 50-day moving average of $201.03 and under its 200-day moving average of $215.48.

More news about Caterpillar.

Most Active Premarket Losers Today

1. Castle Biosciences (CSTL) – Premarket: -4.72%

NASDAQ Composite ended the session with Castle Biosciences jumping 4.39% to $42.82 on Wednesday, following the last session’s upward trend. NASDAQ Composite rose 2.4% to $15,341.09, following the last session’s upward trend on what was an all-around positive trend trading session today.

Volume

Today’s last reported volume for Castle Biosciences is 158794, 28.4% below its average volume of 221785.

Castle Biosciences’s last close was $42.82, 60.24% below its 52-week high of $107.69.

Castle Biosciences’s Sales

Castle Biosciences’s sales growth is 53.2% for the ongoing quarter and 39.2% for the next. The company’s growth estimates for the current quarter and the next is a negative 73.9% and a negative 69.6%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 31%, now sitting on 68.04M for the twelve trailing months.

Volatility

Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was 0.55%, 0.83%, and 3.70%, respectively.

Castle Biosciences’s highest amplitude of average volatility was 4.50% (last week), 3.79% (last month), and 3.70% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Castle Biosciences’s stock is considered to be oversold (<=20).

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $42.82 at 07:34 EST, way below its 52-week high of $107.69 and above its 52-week low of $39.34.

Castle Biosciences’s Moving Average

Castle Biosciences’s worth is way under its 50-day moving average of $54.83 and way below its 200-day moving average of $64.52.

More news about Castle Biosciences.

2. Canopy Growth (CGC) – Premarket: -3.73%

NASDAQ Composite ended the session with Canopy Growth rising 10.4% to $9.66 on Wednesday, after two sequential sessions in a row of gains. NASDAQ Composite jumped 2.4% to $15,341.09, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Volume

Today’s last reported volume for Canopy Growth is 6886160, 0.21% below its average volume of 6901240.

Canopy Growth’s last close was $9.66, 82.9% below its 52-week high of $56.50.

Canopy Growth’s Revenue

Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 572.44M for the twelve trailing months.

Volatility

Canopy Growth’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.74%, a negative 1.77%, and a positive 4.54%, respectively.

Canopy Growth’s highest amplitude of average volatility was 7.55% (last week), 4.38% (last month), and 4.54% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Canopy Growth’s stock is considered to be overbought (>=80).

Canopy Growth’s Stock Yearly Top and Bottom Value

Canopy Growth’s stock is valued at $9.66 at 07:34 EST, way under its 52-week high of $56.50 and higher than its 52-week low of $9.54.

Canopy Growth’s Moving Average

Canopy Growth’s worth is way under its 50-day moving average of $12.63 and way below its 200-day moving average of $20.75.

Previous days news about Canopy Growth

  • Canopy growth stock wilts: A technical analysis. According to Business Insider on Monday, 20 December, "See Also: How To Buy Canopy Growth StockCanopy Growth Daily Chart Analysis Shares have been attempting to cross above the $60 level for a time, as it has held as a strong resistance area for the stock. "

More news about Canopy Growth.

3. Alibaba (BABA) – Premarket: -3.72%

NYSE Composite ended the session with Alibaba jumping 6.94% to $122.98 on Wednesday while NYSE Composite rose 1.84% to $16,744.27.

Volume

Today’s last reported volume for Alibaba is 17683400, 24.03% below its average volume of 23277600.

Alibaba’s last close was $122.98, 56.17% under its 52-week high of $280.61.

News about Alibaba today

  • Alibaba and other tech stocks rally in Hong Kong as hang seng extends rebound. According to today’s article on Benzinga, "Shares of Alibaba Group Holding Limited (NYSE: BABA), Baidu Inc. (NASDAQ: BIDU), JD."
  • China regulators suspend Alibaba cloud partnership; CLSA remains bullish on Alibaba. According to today’s article on Business Insider, "Chinese regulators suspended an information-sharing partnership withAlibaba Group Holding Ltd(NYSE:BABA) Alibaba Cloud Computing,Reuters reports."

The company’s growth estimates for the current quarter and the next is a negative 24.8% and a negative 4.2%, respectively.

Alibaba’s Revenue

Year-on-year quarterly revenue growth grew by 63.9%, now sitting on 717.29B for the twelve trailing months.

Volatility

Alibaba’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.65%, a negative 1.08%, and a positive 2.57%, respectively.

Alibaba’s highest amplitude of average volatility was 4.07% (last week), 2.43% (last month), and 2.57% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Alibaba’s stock is considered to be overbought (>=80).

Alibaba’s Stock Yearly Top and Bottom Value

Alibaba’s stock is valued at $122.98 at 07:34 EST, way below its 52-week low of $138.43.

Alibaba’s Moving Average

Alibaba’s value is way under its 50-day moving average of $161.10 and way under its 200-day moving average of $190.56.

Previous days news about Alibaba

  • Good tidings for Alibaba and other U.S.-listed Chinese firms? regulators make progress on audit inspection talks to avert potential delistings. According to Benzinga on Sunday, 19 December, "Chinese companies listed in the U.S. such as Alibaba Group Holding Limited (NYSE: BABA), Tencent Holdings Limited (PNK: TCEHY) and JD.com, Inc. (NYSE: JD) were already under pressure due to a clampdown by local regulators. ", "Related Link: Alibaba Opens Up Walled Garden To Allow Rival Tencent’s Payment System In Some Apps"
  • Alibaba and other major stocks trade muted in Hong Kong even as PBOC cuts benchmark lending rate for 1st time in 2 years. According to Benzinga on Monday, 20 December, "Shares of Alibaba Group Holding Limited (NYSE: BABA) and Baidu Inc. (NASDAQ: BIDU) traded slightly higherin Hong Kong on Monday, while JD.", "What’s Moving: Shares of Alibaba and Baidu traded about 1% higher each in Hong Kong at the time of writing, while JD."

More news about Alibaba.

4. Bilibili (BILI) – Premarket: -3.16%

NASDAQ Composite ended the session with Bilibili jumping 11.71% to $49.31 on Wednesday while NASDAQ Composite jumped 2.4% to $15,341.09.

Volume

Today’s last reported volume for Bilibili is 9761960, 109.51% above its average volume of 4659370.

Bilibili’s last close was $49.31, 68.72% under its 52-week high of $157.66.

Bilibili’s Sales

Bilibili’s sales growth is 61.3% for the current quarter and 52.5% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 52.4% and a negative 75.9%, respectively.

Bilibili’s Revenue

Year-on-year quarterly revenue growth grew by 71.7%, now sitting on 15.46B for the twelve trailing months.

Volatility

Bilibili’s last week, last month’s, and last quarter’s current intraday variation average was a negative 8.17%, a negative 4.04%, and a positive 4.88%, respectively.

Bilibili’s highest amplitude of average volatility was 11.51% (last week), 5.45% (last month), and 4.88% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Bilibili’s stock is considered to be oversold (<=20).

Bilibili’s Stock Yearly Top and Bottom Value

Bilibili’s stock is valued at $49.31 at 07:34 EST, way under its 52-week high of $157.66 and way higher than its 52-week low of $43.88.

Bilibili’s Moving Average

Bilibili’s value is way under its 50-day moving average of $73.48 and way below its 200-day moving average of $91.08.

More news about Bilibili.

5. Roper Industries (ROP) – Premarket: -2.59%

NYSE Composite ended the session with Roper Industries jumping 1.12% to $472.22 on Wednesday, after two successive sessions in a row of gains. NYSE Composite rose 1.84% to $16,744.27, following the last session’s upward trend on what was an all-around up trend exchanging session today.

Volume

Today’s last reported volume for Roper Industries is 227352, 39.09% below its average volume of 373287.

Roper Industries’s last close was $472.22, 6.49% below its 52-week high of $505.00.

Roper Industries’s Sales

Roper Industries’s sales growth is 18.8% for the current quarter and 11% for the next. The company’s growth estimates for the current quarter and the next is 21.5% and 11.8%, respectively.

Roper Industries’s Revenue

Year-on-year quarterly revenue growth grew by 21.7%, now sitting on 5.99B for the twelve trailing months.

Volatility

Roper Industries’s last week, last month’s, and last quarter’s current intraday variation average was 0.38%, 0.06%, and 1.04%, respectively.

Roper Industries’s highest amplitude of average volatility was 2.49% (last week), 1.06% (last month), and 1.04% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Roper Industries’s stock is considered to be overbought (>=80).

Roper Industries’s Stock Yearly Top and Bottom Value

Roper Industries’s stock is valued at $472.22 at 07:34 EST, below its 52-week high of $505.00 and way above its 52-week low of $365.23.

Roper Industries’s Moving Average

Roper Industries’s value is higher than its 50-day moving average of $469.05 and above its 200-day moving average of $467.40.

More news about Roper Industries.

6. TherapeuticsMD (TXMD) – Premarket: -2.36%

NASDAQ Composite ended the session with TherapeuticsMD jumping 2.02% to $0.42 on Wednesday while NASDAQ Composite jumped 2.4% to $15,341.09.

Volume

Today’s last reported volume for TherapeuticsMD is 3415480, 27.6% below its average volume of 4717860.

TherapeuticsMD’s last close was $0.42, 84.73% under its 52-week high of $2.75.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the present quarter and 29.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.

Volatility

TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.72%, a negative 2.73%, and a positive 5.92%, respectively.

TherapeuticsMD’s highest amplitude of average volatility was 4.84% (last week), 8.15% (last month), and 5.92% (last quarter), respectively.

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $0.42 at 07:34 EST, way under its 52-week high of $2.75 and way above its 52-week low of $0.37.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s value is way below its 50-day moving average of $0.66 and way below its 200-day moving average of $1.00.

More news about TherapeuticsMD.

7. Pinduoduo (PDD) – Premarket: -2.34%

NASDAQ Composite ended the session with Pinduoduo jumping 8.27% to $59.31 on Wednesday while NASDAQ Composite jumped 2.4% to $15,341.09.

Volume

Today’s last reported volume for Pinduoduo is 6598460, 12.1% below its average volume of 7506790.

Pinduoduo’s last close was $59.31, 72.1% under its 52-week high of $212.60.

The company’s growth estimates for the ongoing quarter is a negative 160% and positive 1350% for the next.

Pinduoduo’s Revenue

Year-on-year quarterly revenue growth grew by 89%, now sitting on 85.97B for the twelve trailing months.

Volatility

Pinduoduo’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.96%, a negative 1.98%, and a positive 3.97%, respectively.

Pinduoduo’s highest amplitude of average volatility was 5.85% (last week), 4.75% (last month), and 3.97% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pinduoduo’s stock is considered to be overbought (>=80).

Pinduoduo’s Stock Yearly Top and Bottom Value

Pinduoduo’s stock is valued at $59.31 at 07:34 EST, way under its 52-week high of $212.60 and way higher than its 52-week low of $51.91.

Pinduoduo’s Moving Average

Pinduoduo’s worth is way under its 50-day moving average of $84.55 and way under its 200-day moving average of $108.96.

More news about Pinduoduo.

8. DouYu (DOYU) – Premarket: -2.28%

NASDAQ Composite ended the session with DouYu jumping 6.05% to $2.63 on Wednesday while NASDAQ Composite jumped 2.4% to $15,341.09.

Volume

Today’s last reported volume for DouYu is 1525010, 47.4% below its average volume of 2899560.

DouYu’s last close was $2.63, 87.2% under its 52-week high of $20.54.

The company’s growth estimates for the current quarter is a negative 183.3% and positive 57.1% for the next.

DouYu’s Revenue

Year-on-year quarterly revenue growth declined by 6.8%, now sitting on 9.31B for the twelve trailing months.

Volatility

DouYu’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.10%, a negative 0.91%, and a positive 4.85%, respectively.

DouYu’s highest amplitude of average volatility was 7.38% (last week), 5.42% (last month), and 4.85% (last quarter), respectively.

DouYu’s Stock Yearly Top and Bottom Value

DouYu’s stock is valued at $2.63 at 07:34 EST, way below its 52-week high of $20.54 and way above its 52-week low of $1.98.

DouYu’s Moving Average

DouYu’s worth is way under its 50-day moving average of $3.21 and way under its 200-day moving average of $6.30.

More news about DouYu.

9. Exact Sciences (EXAS) – Premarket: -2.25%

NASDAQ Composite ended the session with Exact Sciences jumping 3.95% to $82.40 on Wednesday, following the last session’s upward trend. NASDAQ Composite jumped 2.4% to $15,341.09, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Volume

Today’s last reported volume for Exact Sciences is 1552040, 5.52% below its average volume of 1642750.

Exact Sciences’s last close was $82.40, 48.35% below its 52-week high of $159.54.

Exact Sciences’s Sales

Exact Sciences’s sales growth is 27.6% for the current quarter and a decline by 1% for the next. The company’s growth estimates for the current quarter and the next is 41.8% and 67%, respectively.

Exact Sciences’s Revenue

Year-on-year quarterly revenue growth grew by 15.6%, now sitting on 1.55B for the twelve trailing months.

Volatility

Exact Sciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.56%, a positive 0.33%, and a positive 2.66%, respectively.

Exact Sciences’s highest amplitude of average volatility was 3.52% (last week), 3.16% (last month), and 2.66% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Exact Sciences’s stock is considered to be oversold (<=20).

Exact Sciences’s Stock Yearly Top and Bottom Value

Exact Sciences’s stock is valued at $82.40 at 07:34 EST, way below its 52-week high of $159.54 and way above its 52-week low of $73.41.

Exact Sciences’s Moving Average

Exact Sciences’s value is below its 50-day moving average of $91.06 and way under its 200-day moving average of $108.51.

More news about Exact Sciences.

10. Genworth Financial (GNW) – Premarket: -2.24%

NYSE Composite ended the session with Genworth Financial jumping 4.16% to $4.01 on Wednesday, following the last session’s upward trend. NYSE Composite rose 1.84% to $16,744.27, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Volume

Today’s last reported volume for Genworth Financial is 1560390, 52.65% below its average volume of 3295990.

Genworth Financial’s last close was $4.01, 15.76% below its 52-week high of $4.76.

Genworth Financial’s Sales

Genworth Financial’s sales growth is a negative 19.2% for the present quarter and a decline by 11.2% for the next. The company’s growth estimates for the current quarter and the next is a negative 75.6% and a negative 48.1%, respectively.

Genworth Financial’s Revenue

Year-on-year quarterly revenue growth grew by 8.1%, now sitting on 8.83B for the twelve trailing months.

Volatility

Genworth Financial’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.01%, a negative 0.59%, and a positive 2.05%, respectively.

Genworth Financial’s highest amplitude of average volatility was 2.01% (last week), 1.85% (last month), and 2.05% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Genworth Financial’s stock is considered to be overbought (>=80).

Genworth Financial’s Stock Yearly Top and Bottom Value

Genworth Financial’s stock is valued at $4.01 at 07:34 EST, way under its 52-week high of $4.76 and way above its 52-week low of $2.56.

Genworth Financial’s Moving Average

Genworth Financial’s worth is under its 50-day moving average of $4.16 and above its 200-day moving average of $3.90.

More news about Genworth Financial.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here